GXYLT1P6: A Potential Drug Target and Biomarker (G100132672)

GXYLT1P6: A Potential Drug Target and Biomarker

G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GXYLT1P6 is a GPCR that has been identified as a potential drug target and biomarker.

The GXYLT1P6 gene encodes a protein that is expressed in various tissues and organs, including the brain, heart, kidneys, and liver. The protein is a 14kDa transmembrane protein that consists of an extracellular region, a transmembrane region, and an intracellular region. The GXYLT1P6 protein is known to play a role in neurotransmission and has been implicated in various neurological and psychiatric disorders.

GXYLT1P6 has been shown to regulate the release of neurotransmitters, such as dopamine and GABA, from the axon terminal of dopamine-producing neurons. The GXYLT1P6 protein has been shown to interact with the neurotransmitter receptors, including D2 and D3, which are involved in the uptake and release of neurotransmitters.

GXYLT1P6 has also been shown to play a role in pain perception and neuroinflammation. The GXYLT1P6 protein has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪, IL-1尾, and IL-6, which are involved in the development of pain and neuroinflammation.

GXYLT1P6 has also been shown to be involved in the modulation of neurotransmitter release and cell signaling. The GXYLT1P6 protein has been shown to interact with various intracellular signaling pathways, including the protein kinase CK2, which is involved in the modulation of neurotransmitter release and cell signaling.

GXYLT1P6 has been shown to be involved in the development of various psychiatric disorders, including depression, anxiety, and schizophrenia. The GXYLT1P6 protein has been shown to interact with the neurotransmitter receptors D2 and D3, which are involved in the uptake and release of neurotransmitters.

GXYLT1P6 has also been shown to be involved in the regulation of lifespan. The GXYLT1P6 protein has been shown to interact with the protein p53, which is involved in the regulation of cell signaling and lifespan.

GXYLT1P6 has been shown to be involved in the regulation of tissue homeostasis. The GXYLT1P6 protein has been shown to interact with the protein TrkB, which is involved in the regulation of cell signaling and tissue homeostasis.

GXYLT1P6 has also been shown to play a role in the regulation of gene expression. The GXYLT1P6 protein has been shown to interact with the protein NF-kappa-B, which is involved in the regulation of gene expression.

GXYLT1P6 has been shown to be involved in the development of various diseases, including neurodegenerative disorders, psychiatric disorders, and cardiovascular diseases. The GXYLT1P6 protein has been shown to interact with the neurotransmitter receptors D2 and D3, which are involved in the uptake and release of neurotransmitters.

GXYLT1P6 has also been shown to be involved in the regulation of inflammation. The GXYLT1P6 protein has been shown to interact with the protein NF-kappa-B, which is involved in the regulation of inflammation.

GXYLT1P6 has been shown to play a role in

Protein Name: GXYLT1 Pseudogene 6

The "GXYLT1P6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GXYLT1P6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7